Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control

Cell Cycle

Volumn 10, Issue 10, 2011, Pages 1548-1556

  Rodríguez, Amaia ^a,b   Catalán, Victoria ^a,b   Gómez Ambrosi, Javier ^a,b   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Aquaporin; Atp production; Fat accumulation; Glucose homeostasis; Glycerol; Insulin secretion

Indexed keywords

AQUAGLYCEROPORIN; AQUAGLYCEROPORIN 10; AQUAGLYCEROPORIN 3; AQUAGLYCEROPORIN 7; AQUAGLYCEROPORIN 9; CATECHOLAMINE; CD36 ANTIGEN; CHYLOMICRON; DIHYDROXYACETONE PHOSPHATE; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GLUCOSE TRANSPORTER 4; GLYCEROL; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL KINASE; HORMONE SENSITIVE LIPASE; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PIOGLITAZONE; PYRUVATE CARBOXYLASE; RECOMBINANT HUMAN INSULIN; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; GLUCONEOGENESIS; GLYCOLYSIS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN RESISTANCE; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MISSENSE MUTATION; MYOFILAMENT; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79956028093     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.10.15672     Document Type: Review

References (80)

1. Frühbeck G, Gómez-Ambrosi J. Rationale for the existence of additional adipostatic hormones. FASEB J 2001; 15:1996-2006. (Pubitemid 32848804)
2. Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr Pharm Des 2007; 13:2169-75.
3. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity 2006; 14:336-41. (Pubitemid 46214766)
4. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640-9. (Pubitemid 41552419)
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-28. (Pubitemid 40523737)
6. Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 1991; 15:853-9.
7. Gómez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, et al. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg 2007; 17:585-91. (Pubitemid 46945414)
8. Maeda N, Funahashi T, Shimomura I. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab 2008; 4:627-34.
9. Hibuse T, Maeda N, Nagasawa A, Funahashi T. Aquaporins and glycerol metabolism. Biochim Biophys Acta 2006; 1758:1004-11. (Pubitemid 44373851)
10. King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol 2004; 5:687-98. (Pubitemid 39208179)
11. Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett 2003; 555:72-8. (Pubitemid 37431100)
12. Jung JS, Preston GM, Smith BL, Guggino WB, Agre P. Molecular structure of the water channel through aquaporin CHIP. The hourglass model. J Biol Chem 1994; 269:14648-54.
13. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 1994; 91:13052-6.
14. Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, et al. Aquaporin water channels - from atomic structure to clinical medicine. J Physiol 2002; 542:3-16. (Pubitemid 35190266)
15. Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC, et al. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem 2003; 278:30413-6. (Pubitemid 36994541)
16. Frühbeck G. Obesity: aquaporin enters the picture. Nature 2005; 438:436-7. (Pubitemid 41742005)
17. Frühbeck G, Catalán V, Gómez-Ambrosi J, Rodríguez A. Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends Pharmacol Sci 2006; 27:345-7. (Pubitemid 43963182)
18. Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G. Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice. FEBS Lett 2006; 580:4771-6. (Pubitemid 44286845)
19. Hibuse T, Maeda N, Nakatsuji H, Tochino Y, Fujita K, Kihara S, et al. The heart requires glycerol as an energy substrate through aquaporin 7, a glycerol facilitator. Cardiovasc Res 2009; 83:34-41.
20. Miranda M, Escote X, Ceperuelo-Mallafre V, Alcaide MJ, Simon I, Vilarrasa N, et al. Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots. J Clin Endocrinol Metab 2010; 95:3470-9.
21. Rodríguez A, Catalán V, Gómez-Ambrosi J, García-Navarro S, Rotellar F, Valentí V, et al. Insulinand leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab 2011; DOI: 10.1210/jc.2010-1408.
22. Maeda N, Funahashi T, Hibuse T, Nagasawa A, Kishida K, Kuriyama H, et al. Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proc Natl Acad Sci USA 2004; 101:17801-6. (Pubitemid 40051967)
23. Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Curr Genomics 2007; 8:113-28. (Pubitemid 46690959)
24. Kishida K, Shimomura I, Kondo H, Kuriyama H, Makino Y, Nishizawa H, et al. Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel. J Biol Chem 2001; 276:36251-60.
25. Gonzales AM, Orlando RA. Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab 2007; 4:22.
26. Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 2002; 8:1122-8. (Pubitemid 35175967)
27. Gradilone SA, Tietz PS, Splinter PL, Marinelli RA, LaRusso NF. Expression and subcellular localization of aquaporin water channels in the polarized hepatocyte cell line, WIF-B. BMC Physiol 2005; 5:13.
28. Kuriyama H, Shimomura I, Kishida K, Kondo H, Furuyama N, Nishizawa H, et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 2002; 51:2915-21.
29. Kondo H, Shimomura I, Kishida K, Kuriyama H, Makino Y, Nishizawa H, et al. Human aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation. Eur J Biochem 2002; 269:1814-26. (Pubitemid 34429663)
30. Roudier N, Ripoche P, Gane P, Le Pennec PY, Daniels G, Cartron JP, et al. AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL. J Biol Chem 2002; 277:45854-9. (Pubitemid 35417564)
31. Nejsum LN, Kwon TH, Marples D, Flyvbjerg A, Knepper MA, Frokiaer J, et al. Compensatory increase in AQP2, p-AQP2 and AQP3 expression in rats with diabetes mellitus. Am J Physiol Renal Physiol 2001; 280:715-26.
32. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27:435-8.
33. Kishida K, Kuriyama H, Funahashi T, Shimomura I, Kihara S, Ouchi N, et al. Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem 2000; 275:20896-902. (Pubitemid 30457685)
34. Yasui H, Kubota M, Iguchi K, Usui S, Kiho T, Hirano K. Membrane trafficking of aquaporin 3 induced by epinephrine. Biochem Biophys Res Commun 2008; 373:613-7.
35. Walker CG, Holness MJ, Gibbons GF, Sugden MC. Fasting-induced increases in aquaporin 7 and adipose triglyceride lipase mRNA expression in adipose tissue are attenuated by peroxisome proliferator-activated receptor alpha deficiency. Int J Obes 2007; 31:1165-71. (Pubitemid 46987765)
36. Fasshauer M, Klein J, Lossner U, Klier M, Kralisch S, Paschke R. Suppression of aquaporin adipose gene expression by isoproterenol, TNFα and dexamethasone. Horm Metab Res 2003; 35:222-7. (Pubitemid 36754198)
37. Kong CS, Kim JA, Bak SS, Byun HG, Kim SK. Antiobesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes. J Nutr Biochem 2011; 22:276-81.
38. Hibuse T, Maeda N, Funahashi T, Yamamoto K, Nagasawa A, Mizunoya W, et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA 2005; 102:10993-8. (Pubitemid 41105981)
39. Hara-Chikuma M, Sohara E, Rai T, Ikawa M, Okabe M, Sasaki S, et al. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem 2005; 280:15493-6. (Pubitemid 40616663)
40. Marrades MP, Milagro FI, Martínez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun 2006; 339:785-9. (Pubitemid 41772882)
41. Prudente S, Flex E, Morini E, Turchi F, Capponi D, De Cosmo S, et al. A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities. Diabetes 2007; 56:1468-74. (Pubitemid 46715624)
42. Catalán V, Gómez-Ambrosi J, Pastor C, Rotellar F, Silva C, Rodríguez A, et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg 2008; 18:695-701.
43. Miranda M, Ceperuelo-Mallafré V, Lecube A, Hernández C, Chacón MR, Fort JM, et al. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. Metabolism 2009; 58:1762-8.
44. Kishida K, Shimomura I, Nishizawa H, Maeda N, Kuriyama H, Kondo H, et al. Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor γ. J Biol Chem 2001; 276:48572-9.
45. Lee DH, Park DB, Lee YK, An CS, Oh YS, Kang JS, et al. The effects of thiazolidinedione treatment on the regulations of aquaglyceroporins and glycerol kinase in OLETF rats. Metabolism 2005; 54:1282-9.
46. Carbrey JM, Gorelick-Feldman DA, Kozono D, Praetorius J, Nielsen S, Agre P. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc Natl Acad Sci USA 2003; 100:2945-50. (Pubitemid 36297603)
47. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, et al. Immunolocalization of AQP9 in liver, epididymis, testis, spleen and brain. Biochem Biophys Res Commun 2000; 276:1118-28.
48. Ishibashi K, Kuwahara M, Gu Y, Tanaka Y, Marumo F, Sasaki S. Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. Biochem Biophys Res Commun 1998; 244:268-74. (Pubitemid 28419937)
49. Ishibashi K, Sasaki S, Saito F, Ikeuchi T, Marumo F. Structure and chromosomal localization of a human water channel (AQP3) gene. Genomics 1995; 27:352-4.
50. Ma T, Song Y, Yang B, Gillespie A, Carlson EJ, Epstein CJ, et al. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc Natl Acad Sci USA 2000; 97:4386-91.
51. Rojek AM, Skowronski MT, Fuchtbauer EM, Fuchtbauer AC, Fenton RA, Agre P, et al. Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci USA 2007; 104:3609-14. (Pubitemid 46364206)
52. Higuchi S, Kubota M, Iguchi K, Usui S, Kiho T, Hirano K. Transcriptional regulation of aquaporin 3 by insulin. J Cell Biochem 2007; 102:1051-8. (Pubitemid 350036944)
53. Postic C, Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008; 34:643-8.
54. Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 2010; 34:1451-67.
55. Potter JJ, Koteish A, Hamilton J, Liu X, Liu K, Agre P, et al. Effects of Acetaldehyde on Hepatocyte Glycerol Uptake and Cell Size: Implication of Aquaporin 9. Alcohol Clin Exp Res 2011; DOI: 10.1111/j.530-0277.2010.01424.x.
56. Muoio DM, Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9:193-205. (Pubitemid 351301824)
57. Skelly RH, Wicksteed B, Antinozzi PA, Rhodes CJ. Glycerol-stimulated proinsulin biosynthesis in isolated pancreatic rat islets via adenoviral-induced expression of glycerol kinase is mediated via mitochondrial metabolism. Diabetes 2001; 50:1791-8. (Pubitemid 33641598)
58. Matsumura K, Chang BH, Fujimiya M, Chen W, Kulkarni RN, Eguchi Y, et al. Aquaporin 7 is a β-cell protein and regulator of intraislet glycerol content and glycerol kinase activity, β-cell mass and insulin production and secretion. Mol Cell Biol 2007; 27:6026-37.
59. Delporte C, Virreira M, Crutzen R, Louchami K, Sener A, Malaisse WJ, et al. Functional role of aquaglyceroporin 7 expression in the pancreatic β-cell line BRIN-BD11. J Cell Physiol 2009; 221:424-9.
60. Best L, Brown PD, Yates AP, Perret J, Virreira M, Beauwens R, et al. Contrasting effects of glycerol and urea transport on rat pancreatic β-cell function. Cell Physiol Biochem 2009; 23:255-64.
61. + ratio provides evidence of a mitochondrial glycerol-3-phosphate shuttle in Arabidopsis. Plant Cell 2006; 18:422-41.
62. Virreira M, Perret J, Delporte C. Pancreatic β-cells: Role of glycerol and aquaglyceroporin 7. Int J Biochem Cell Biol 2011; 43:10-3.
63. Montell E, Lerin C, Newgard CB, Gomez-Foix AM. Effects of modulation of glycerol kinase expression on lipid and carbohydrate metabolism in human muscle cells. J Biol Chem 2002; 277:2682-6. (Pubitemid 34953295)
64. Wakayama Y, Jimi T, Inoue M, Kojima H, Shibuya S, Murahashi M, et al. Expression of aquaporin 3 and its localization in normal skeletal myofibres. Histochem J 2002; 34:331-7. (Pubitemid 36543077)
65. Wakayama Y, Inoue M, Kojima H, Jimi T, Shibuya S, Hara H, et al. Expression and localization of aquaporin 7 in normal skeletal myofiber. Cell Tissue Res 2004; 316:123-9. (Pubitemid 38669884)
66. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007; 356:1140-51. (Pubitemid 46425598)
67. Skowronski MT, Lebeck J, Rojek A, Praetorius J, Fuchtbauer EM, Frokiaer J, et al. AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism. Am J Physiol Renal Physiol 2007; 292:956-65.
68. Gladka M, El Azzouzi H, De Windt LJ, da Costa Martins PA. Aquaporin 7: the glycerol aquaeductus in the heart. Cardiovasc Res 2009; 83:3-4.
69. Ishibashi K, Yamauchi K, Kageyama Y, Saito-Ohara F, Ikeuchi T, Marumo F, et al. Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping. Biochim Biophys Acta 1998; 1399:62-6. (Pubitemid 28374917)
70. Sjöholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005; 90:2233-9. (Pubitemid 40586267)
71. Ceperuelo-Mallafré V, Miranda M, Chacón MR, Vilarrasa N, Megia A, Gutiérrez C, et al. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J Clin Endocrinol Metab 2007; 92:3640-5. (Pubitemid 47435350)
72. Candreia C, Schmuziger N, Gurtler N. Molecular analysis of aquaporin genes 1 to 4 in patients with Meniere's disease. Cell Physiol Biochem 2010; 26:787-92.
73. Chanprasertyothin S, Saetung S, Rajatanavin R, Ongphiphadhanakul B. Genetic variant in the aquaporin 9 gene is associated with bone mineral density in postmenopausal women. Endocrine 2010; 38:83-6.
74. Nagahara M, Waguri-Nagaya Y, Yamagami T, Aoyama M, Tada T, Inoue K, et al. TNFalphainduced aquaporin 9 in synoviocytes from patients with OA and RA. Rheumatology 2010; 49:898-906.
75. Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins - new players in cancer biology. J Mol Med 2008; 86:523-9.
76. Liu YL, Matsuzaki T, Nakazawa T, Murata S, Nakamura N, Kondo T, et al. Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues. Hum Pathol 2007; 38:171-8. (Pubitemid 44880215)
77. Huang Y, Zhu Z, Sun M, Wang J, Guo R, Shen L, et al. Critical role of aquaporin-3 in the human epidermal growth factor-induced migration and proliferation in the human gastric adenocarcinoma cells. Cancer Biol Ther 2010; 9:1000-7.
78. Melis M, Hernandez J, Siegel EM, McLoughlin JM, Ly QP, Nair RM, et al. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum 2010; 53:936-43.
79. Kusayama M, Wada K, Nagata M, Ishimoto S, Takahashi H, Yoneda M, et al. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci 2011; DOI: 10.1111/j.349-7006.2011.01927.x.
80. Ji C, Cao C, Lu S, Kivlin R, Amaral A, Kouttab N, et al. Curcumin attenuates EGF-induced AQP3 upregulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 2008; 62:857-65.